Bausch Health Companies Inc. (BHC): Price and Financial Metrics

Bausch Health Companies Inc. (BHC)

Today's Latest Price: $18.58 USD

0.06 (0.32%)

Updated May 28 8:04pm

Add BHC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BHC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for BHC is 11.96 -- better than 97.36% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 18.9 for Bausch Health Companies Inc; that's greater than it is for 98.38% of US stocks.
  • Over the past twelve months, BHC has reported earnings growth of -435.63%, putting it ahead of merely 3.97% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Bausch Health Companies Inc, a group of peers worth examining would be CNR, GTT, COMM, SEAS, and NNBR.
  • BHC's SEC filings can be seen here. And to visit Bausch Health Companies Inc's official web site, go to
BHC Daily Price Range
BHC 52-Week Price Range

BHC Stock Price Chart More Charts

BHC Price/Volume Stats

Current price $18.58 52-week high $31.97
Prev. close $18.52 52-week low $11.15
Day low $18.22 Volume 7,139,500
Day high $18.93 Avg. volume 5,455,711
50-day MA $16.40 Dividend yield N/A
200-day MA $22.92 Market Cap 6.54B

Bausch Health Companies Inc. (BHC) Company Bio

Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada.

BHC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for BHC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Bausch Health Companies Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Bausch Health Companies Inc ended up being:

  • In the past 5.77 years, Bausch Health Companies Inc has a compound free cash flow growth rate of 0.01%; that's higher than just 20.99% of free cash flow generating stocks in the Healthcare sector.
  • 21% of the company's capital comes from equity, which is greater than merely 9.48% of stocks in our cash flow based forecasting set.
  • Bausch Health Companies Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.18. This coverage rate is greater than that of merely 20.18% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ZBH, ABT, BIO, ENZ, and TMO can be thought of as valuation peers to BHC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

BHC Latest News Stream

Event/TimeNews Detail
Loading, please wait...

BHC Latest Social Stream

Loading social stream, please wait...

View Full BHC Social Stream

Latest BHC News From Around the Web

Below are the latest news stories about Bausch Health Companies Inc that investors may wish to consider to help them evaluate BHC as an investment opportunity.

Anterix and Bausch Holding See Activist Action

Owl Creek Asset Management increased its stake in wireless-communications firm Anterix, while Paulson & Co. bought more Bausch stock.

Yahoo | May 22, 2020

Francis Chou Slims 4 Positions in the 1st Quarter

Canadian guru releases portfolio. Sells include major Berkshire bank holding Bank of America. Continue reading...

Yahoo | May 22, 2020

Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference

LAVAL, Quebec, May 21, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate…

PR Newswire | May 21, 2020

Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization

LAVAL, Quebec, May 11, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offering of $1,500,000,000 aggregate principal amount of 6.250% senior notes due 2029 (the…

PR Newswire | May 11, 2020

COVID-19 Impact and Recovery Analysis- Global Chemical Peel Market 2020-2024 | Evolving Opportunities with Allergan Plc and Bausch Health Companies Inc. | Technavio

LONDON--(BUSINESS WIRE)-- #ChemicalPeelMarket--The chemical peel market is poised to grow by 62.78 mn during 2020-2024, according to Technavio

Business Wire | May 8, 2020

Read More 'BHC' Stories Here

BHC Price Returns

1-mo 1.03%
3-mo -16.04%
6-mo -34.21%
1-year -13.38%
3-year 51.80%
5-year N/A
YTD -37.90%
2019 61.99%
2018 -11.12%
2017 43.11%
2016 -85.72%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.8321 seconds.